To determine whether the antitumor effects of miR-382 on these CRC cells could be partly explained by its targeting of KLF12 and HIPK3, we confirmed how KLF12 and HIPK3 overexpression affected cell growth and chemosensitivity in vitro and in vivo. The gene discussed is KLF12; the disease is colorectal carcinoma.